Eco Animal Health to develop poultry vaccine with Ghent University

Writer, Stock Market Wire
Wednesday, February 13, 2019 - 14:48

Eco Animal Health said it had signed a poultry vaccine development licencing deal with Ghent University in Belgium.

The deal would allows Eco to further develop, register and commercialize a Clostridium perfringens vaccine for poultry based on antigens co-developed by academics at Ghent University and the University of Exeter.

At 2:48pm: (LON:EAH) Eco Animal Health Group PLC share price was 0p at 475p

Related content

Eco Animal Health forms vaccine research pact for chicken diseases

Eco Animal Health said it had entered into a second exclusive research partnership with the UK's Pirbright Institute, to develop another novel vaccine for use...

Wed, 11/09/2019 - 14:51

Eco Animal Health profits jump 10%, but US-China trade war, African Swine Fever stifle growth

ECO Animal Health reported a 10% jump in profits, but the outbreak of African Swine Fever and a trade war between the USA and China...

Wed, 19/06/2019 - 09:03

Broker Forecast - Peel Hunt issues a broker note on Eco Animal Health Group PLC

Peel Hunt today reaffirms its buy investment rating on Eco Animal Health Group PLC (LON:EAH) and cut its price target to 600p (from 725p).


Wed, 19/06/2019 - 08:30

Eco Animal Health gets regulatory nod in India for chicken egg treatment

Eco Animal Health Group said it had received a marketing authorisation from Indian authorities for use of its antimicrobial treatment in chickens laying eggs for...

Tue, 05/03/2019 - 14:09

ECO Animal Health signs second licensing deal with Poultry Diagnostic & Research Center

ECO Animal Health Group's subsidiary ECO Animal Health said Tuesday it had signed a second global exclusive licensing deal with the Poultry Diagnostic & Research...

Tue, 05/02/2019 - 10:48